RecruitingNCT05355415

Adaptive Optics Imaging of Outer Retinal Diseases


Sponsor

Food and Drug Administration (FDA)

Enrollment

100 participants

Start Date

Aug 27, 2021

Study Type

OBSERVATIONAL

Conditions

Summary

The objective of the study is to collect adaptive optics (AO) retinal images from human subjects with outer retinal diseases (diseases of the outer retina including photoreceptor, retinal pigment epithelium (RPE), basement membrane or choroidal pathologies) to develop new diagnostic methods, biomarkers, and clinical endpoints.


Eligibility

Min Age: 21 Years

Plain Language Summary

Simplified for easier understanding

This study is using a highly advanced imaging technology called Adaptive Optics (AO) to take extremely detailed pictures of the retina (the back of the eye) in patients with outer retinal diseases — conditions affecting the light-sensitive layers of the eye. The goal is to better understand how these conditions affect retinal cells over time. You may be eligible if... - You are 21 years old or older - You have been diagnosed with an outer retinal disease or condition - You are able to follow instructions and sit still for an eye exam - You can read and sign an informed consent in English You may NOT be eligible if... - You have unstable eye fixation or media opacity that prevents good images - Your vision correction (glasses prescription) is outside the range of +4 to -8 diopters - You have had a bad reaction to eye-dilating drops before - You have a history of acute angle-closure glaucoma or a predisposition to it - You work directly under the study investigators at NIH/NEI Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEAdaptive optics imaging

Adaptive optics scanning laser ophthalmoscopy (AOSLO) and adaptive optics - optical coherence tomography (AO-OCT) retinal imaging


Locations(2)

NIH Clinical Center

Bethesda, Maryland, United States

Food and Drug Administration

Silver Spring, Maryland, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05355415


Related Trials